comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 09:45:52 - browse：437

Amylyx founders — Justin Klee (left) and Joshua Cohen are the co-founders and co-CEOs of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any benefit for patients in a large clinical trial — a stunning outcome that now has the company considering a voluntary withdrawal of the approved medicine from the market.

“This is really hard for us, and it’s really hard for our team who care so much, but it’s so much harder for people with ALS and their families, and we have to keep that perspective,” said a somber Justin Klee, Amylyx’s co-founder and co-CEO, in an interview with STAT on Thursday evening.

In the Phase 3 study involving 664 people with ALS, Relyvrio failed to outperform a placebo on an ALS functional rating scale that measures the ability to perform daily living tasks, walk, breathe, speak, and swallow. The company did not provide detailed results for the study’s primary goal, but said the calculation for statistical significance was 0.67 — well above the 0.05 threshold for success and an indication that Relyvrio provided no benefit at all.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Eyeing GLP

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Fentanyl is making it harder to start addiction treatment

Digital health: a case of mistaken identity

As a primary care physician, here's how I hope to partner with AI

GOP inquiry over gain

UnitedHealth wins $3.3 billion takeover of Amedisys

knowledge

comprehensive

hotspot

Apple is now the first public company to be valued at $3 trillion

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

In Memoriam: Notable people who died in 2023

ADA: All diabetes patients should be screened for liver condition

Heart attack and stroke risk calculators need revising

UnitedHealth wins $3.3 billion takeover of Amedisys

BioMarin wins approval for gene therapy to treat hemophilia A

The simple reason for the increase in autism diagnosis

George Santos makes 1st court appearance after pleading not guilty to 13 counts

ADA: All diabetes patients should be screened for liver condition

focus

Medical experts exlpore how to eliminate bias in clinical algorithms

ASCO eve: Let’s set the table for this year's meeting

Reports of telehealth's death have been greatly exaggerated

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

ASCO eve: Let’s set the table for this year's meeting

Listen: More tumult at BIO & coercive care for sickle cell patients

entertainment

explore

focus

Wikipedia